• 2021

Duchemin C et al. on behalf of the MEDICIS collaboration, CERN-MEDICIS: a review since commissioning in 2017. Submitted to Frontiers in Medicine - Research Topic MEDICIS-Promed: Advances in Radioactive Ion Beams for Nuclear Medicine (2021)

Duchemin C., Cocolios T. E., Dockx K., Farooq-Smith G., Felden O., Formento-Cavaier R., Gebel R., Köster U., Neumaier B., Scholten B., Spahn I., Spellerberg S., Stamati N., Stegemann S., Verhoeven H. Production cross-section measurements for terbium radionuclides of medical interest produced in tantalum targets irradiated by 0.3 GeV to 1.7 GeV protons and corresponding thick target yield calculations. Frontiers in Medicine (2021), doi: 10.3389/fmed.2021.625561

Van de Voorde M., Duchemin C., Heinke R., Lambert L., Chevallay E., Schneider T., Van Stenis M., Cocolios T.E., Cardinaels T., Ponsard B., Ooms M., Stora T., Burgoyne A., Production of Sm-153 with very high specific activity for targeted radionuclide therapy, Submitted to Frontiers in Medicine (2021).

Talip Z., Borgna F., Müller C., Ulrich J., Duchemin C., Ramos J.P., Stora T., Köster U., Nedjadi Y., Gadelshin V., Fedosseev V., Juget F., Bailat C., Frankhauser A., Wilkins S., Lambert L., Marsh B., Fedorov D., Chevallay E., Fernier P., Schibli R., Van Der Meulen N., Production of mass separated erbium-169 towards the first preclinical in vitro investigations. Frontiers in Medicine (2021), doi: 10.3389/fmed.2021.643175

Chevallay E, Duchemin C, Heinke R, Khalid U, Lambert L, Stora T. MEDICIS and MELISSA operation in 2020 during LS2. ISOLDE Newsletter (2021). 

D'Onofrio A., Gano L., Melo R., Mendes F., Oliveira M. C., Denoël T., Schaefer N., Viertl D., Fierle J., Coukos G., Dunn S., Prior J. O., Paulo A., "Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies" European Journal of Pharmaceutics and Biopharmaceutics, Vol. 8, 2021, 233-244.

D'Onofrio A.,Silva F., Gano L., Karczmarczyk U., Mikolajczak R., Garnuszek P., Paulo A., "Clickable Radiocomplexes with Trivalent Radiometals for Cancer Theranostics: In Vitro and in Vivo Studies" In review process Frontiers in Medicine - Research Topic MEDICIS-Promed: Advances in Radioactive Ion Beams for Nuclear Medicine (2021)

  • 2020

Duchemin C., Ramos J.P., Stora T., Aubert E., Audouin N., Barbero E., Barozier V., Bernardes A.P., Bertreix P., Boscher A., Burnel D., Catherall R., Cirilli M., Chevallay E., Cocolios T.E., Comte J., Crepieux B., Deschamps M., Dockx K., Dorsival A., Fedosseev V.N., Fernier P., Formento-Cavaier R., Gadelshin V.M., Gilardoni S., Grenard J.L., Haddad F., Heinke R., Juif B., Khan M., Köster U., Lambert L., Lilli G., Lunghi G., Marsh B.A., Martinez Palenzuela Y., Martins R., Marzari S., Menaa N., Michel N., Pozzi F., Riccardi F., Riegert J., Riggaz N., Rothe S., Stegemann S., Talip Z., Thiboud J., van der Meulen N.P., Vollaire J., Vuong N.T., Wendt K., Wilkins S., on behalf of the CERN-MEDICIS collaboration. CERN-MEDICIS: a unique facility for the production of non-conventional radionuclides for the medical research. Published in IPAC'20 JaCoW Proceedings (2020).

Cicone F, Denoël T, Gnesin S, Riggi N, Irving M, Jakka G, Schaefer N, Viertl, D, Coukos G, Prior JO. Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1). Mol Imaging Biol. 2020 Jan 28. doi: 10.1007/s11307-020-01479-8. Erratum in: Mol Imaging Biol. 2020 Mar 20;

Duchemin C, Heinke R, Lambert L, Ramos J.P, Stora T, Wilkins S. MEDICIS and MELISSA operation in 2019 during LS2. ISOLDE Newsletter (2020).

Formento-Cavaier R, Köster U, Crepieux B, Gadelshin V.M, Haddad F, Stora T, Wendt K. Very high specific activity erbium 169Er production for potential receptor-targeted therapy. NIMB Vol.463 (2020) 468-471.

Gadelshin V.M, Barozier V, Cocolios T.E, Fedoseev V.N, Formento-Cavaier R, Haddad F, Marsh B, Marzari S, Rothe S, Stora T, Studer D, Wendt K. MELISSA: Laser Ion Source setup at CERN-MEDICIS facility. NIMB Vol.463 (2020) 460-463.

Gadelshin V.M, Wilkins S. and the MEDICIS collaboration, First laser ions at the CERN-MEDICIS facility. Hyperfine interactions 241 (2020) Article number:55.

Stegemann S, Cocolios T.E, Dockx K, Leinders G, Popescu L, Ramos J.P, Rijpstra K, Stora T, Verwerft M, Vleugels J. NIMB Vol. 463 (2020) 403-407.

  • 2019

Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K, Amato E, Auditore L, Coukos G, Stabin M, Schaefer N, Viertl D, Prior JO. Internal radiation dosimetry of a (152)Tb-labeled antibody in tumor-bearing mice. EJNMMI Res. 2019 Jun 11;9(1):53. doi:10.1186/s13550-019-0524-7

Gadelshin V, Heinke R, Kieck T, Kron T, Naubereit P, Rösch F, Stora T, Studer D, Wendt K. Measurement of the laser resonance ionization efficiency for lutetium. Radiochemica Acta Vol. 170, Issue 7.

Serikbayeva G, Separation device for molecular isotopes at MEDICIS. CERN-STUDENTS-Note-2019-039

  • 2018

Ruiz Quiros A. A chromatographic method to separate Sc(III) from Zn(II) ions: a step in the purification of 44Sc (an isotope of medical interest). CERN-STUDENTS-Note-2018-172

  • 2017

Cocolios T.E, Ferrari C, Reid F, Stora T. MEDICIS-Promed: an innovative training network for a new generation of professionals in nuclear medicine. In: Eskola H, Väïsänen O, Viik J,Hyttinen J. (eds) EMBEC & NBC 2017. EMBEC 2017, NBC 2017, IFMBE proceedings Vol.65. Springer, Singapour.

Formento-Cavaier R, Haddad F, Sounalet T, Stora T, Zahi I. Terbium radionuclides for theranostics applications: a focus on MEDICIS-Promed. Physics Procedia Vol.90 (2017) 157-163.

Gadelshin V, Cocolios T.E, Fedoseev V.N, Heinke R, Kieck T., Marsh B.A, Naubereit P, Rothe S, Stora T, Studer D, Van Duppen P, Wendt K. Hypefine Interactions 238 (2017) 28-34.

  • 2016

Viertl D, Buchegger F, Prior J.O, Morel Ph, Ratib O, Buhler L, Stora T. MEDICIS-Promed: Medicis-produced radioisotope beams for medicine - an innovative training network.

  • 2014

Dos Santos Augusto R.M, Buehler L, Lawson Z, Marzari S, Stachura M, Stora T, and the CERN-MEDICIS collaboration, CERN-MEDICIS(MEDical Isotopes Collected from ISolde): a new facility. Applied Sciences Vol.4 Issue 2 (2014) 265-281. doi: 10.3390/app4020265